Avalo Therapeutics (AVTX) Other Non-Current Liabilities (2015 - 2026)
Avalo Therapeutics' Other Non-Current Liabilities was $18.53 million in Q2 2026, up 80.6% from $10.26 million a year earlier and up 5.8% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Avalo Therapeutics came in at $18 million, up 112.3% from FY2024.
- Other Non-Current Liabilities has now increased for seven consecutive years, with a five-year compound annual growth rate of 57.2% (FY2020 to FY2025).
- In earlier years, Other Non-Current Liabilities was $8.48 million in FY2024 (+52.8%), $5.55 million in FY2023 (+14.9%), $4.83 million in FY2022 (+110.2%) and $2.3 million in FY2021 (+22.4%).
- Quarterly Other Non-Current Liabilities has moved between $1.4 million (Q3 2021) and $23.16 million (Q3 2025) over five years.
- Compared with a year earlier, Other Non-Current Liabilities has increased for four straight quarters, with growth averaging 79.9% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q3 2023 (growth of 176.4%); the worst was Q3 2021 (a decline of 27.8%).
- Per Business Quant data, AVTX's Other Non-Current Liabilities in the three quarters before Q2 2026 was $17.52 million (Q1 2026), $18 million (Q4 2025) and $23.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.53 Mn |
| Mar 31, 2026 | 17.52 Mn |
| Dec 31, 2025 | 18.00 Mn |
| Sep 30, 2025 | 23.16 Mn |
| Jun 30, 2025 | 10.26 Mn |
| Mar 31, 2025 | 7.74 Mn |
| Dec 31, 2024 | 8.48 Mn |
| Sep 30, 2024 | 11.81 Mn |
| Jun 30, 2024 | 10.71 Mn |
| Mar 31, 2024 | 5.67 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 5.05 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 4.83 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.94 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 1.40 Mn |
API Access
Avalo Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();